Company intelligence / Profile preview

Spatial Transcriptomics

Stockholm, Sweden

Ownership: Private
Development stage: Other

Overview

Spatial Transcriptomics, founded in Sweden, pioneered high-resolution tissue gene expression mapping, providing products and services for research in oncology, neuroscience, and other life science fields. The company’s technology enabled scientists to visualize gene expression in tissue sections, laying the groundwork for modern spatial genomics. The platform greatly expanded spatial biology research before the company was acquired and integrated into 10x Genomics.

Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Spatial Transcriptomics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Spatial Transcriptomics.

Explore the full profile